Target intelligence / Profile preview

Myomesin-3 (MYOM3)

Target
MYOM3
Molecular classification
Structural protein, Immunoglobulin superfamily, Fibronectin type III domain–containing protein, Part of the myomesin protein family
01

Overview

Myomesin-3 (MYOM3) is a member of the myomesin protein family, predominantly found in the M-band region of the sarcomere in striated muscle cells. It is primarily expressed in skeletal muscle fibers of intermediate contraction speed and in specific regions of the adult heart, including the left ventricle and atrial appendage. Structurally, MYOM3 consists of a unique N-terminal domain, followed by two immunoglobulin-like domains, five fibronectin type III domains, and five additional immunoglobulin-like domains. It provides mechanical stability by cross-linking myosin and titin filaments, contributing to sarcomere elasticity and muscle contraction mechanics. MYOM3 forms homodimers but does not heterodimerize with other myomesin family members. Although its tissue-specific expression suggests important mechanical and possibly signaling roles within certain muscle types, MYOM3 remains poorly characterized in terms of molecular interactions and disease relevance. Its function and disease associations are still under investigation, though it is considered part of a protein family increasingly linked to muscle and cardiovascular disease pathology.

Other names
MYOM3Myomesin-3Myomesin family member 3FLJ35961
02

Mechanism of action

None known

03

Biological functions

Sarcomere assemblySarcomere structural integrityMuscle contraction mechanicsPossible involvement in injury response within muscle fibers
04

Disease associations

Cardiovascular disease (putative; research is ongoing)
05

Safety considerations

None documented
06

Interacting drugs

None known
07

Biomarkers

Potential: Myomesin family proteins (especially myomesin-1, not specifically myomesin-3) have been suggested as biomarkers for muscle damage, but direct evidence for MYOM3 as a clinical biomarker is lacking

Beyond the preview

Go deeper on Myomesin-3 (MYOM3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Myomesin-3 (MYOM3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call